MIRUM PHARMACEUTICALS, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of April 17, 2023 4.00% Convertible Senior Notes due 2029Indenture • April 17th, 2023 • Mirum Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 17th, 2023 Company Industry JurisdictionINDENTURE, dated as of April 17, 2023, between Mirum Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).